Your browser doesn't support javascript.
loading
A COVID-19-ready public health surveillance system: The Food and Drug Administration's Sentinel System.
Cocoros, Noelle M; Fuller, Candace C; Adimadhyam, Sruthi; Ball, Robert; Brown, Jeffrey S; Dal Pan, Gerald J; Kluberg, Sheryl A; Lo Re, Vincent; Maro, Judith C; Nguyen, Michael; Orr, Robert; Paraoan, Dianne; Perlin, Jonathan; Poland, Russell E; Driscoll, Meighan Rogers; Sands, Kenneth; Toh, Sengwee; Yih, W Katherine; Platt, Richard.
Affiliation
  • Cocoros NM; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Fuller CC; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Adimadhyam S; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Ball R; US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Brown JS; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Dal Pan GJ; US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Kluberg SA; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Lo Re V; Division of Infectious Diseases, Department of Medicine, and Center for Pharmacoepidemiology Research and Training, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Maro JC; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Nguyen M; US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Orr R; US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Paraoan D; US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Perlin J; HCA Healthcare, Nashville, Tennessee, USA.
  • Poland RE; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Driscoll MR; HCA Healthcare, Nashville, Tennessee, USA.
  • Sands K; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Toh S; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Yih WK; HCA Healthcare, Nashville, Tennessee, USA.
  • Platt R; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Pharmacoepidemiol Drug Saf ; 30(7): 827-837, 2021 07.
Article in En | MEDLINE | ID: mdl-33797815
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Product Surveillance, Postmarketing / United States Food and Drug Administration / Public Health Surveillance / Health Information Management / COVID-19 Type of study: Guideline / Prognostic_studies / Screening_studies Limits: Humans Country/Region as subject: America do norte Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Product Surveillance, Postmarketing / United States Food and Drug Administration / Public Health Surveillance / Health Information Management / COVID-19 Type of study: Guideline / Prognostic_studies / Screening_studies Limits: Humans Country/Region as subject: America do norte Language: En Year: 2021 Type: Article